MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)

• Status: Completed
• Trial end date: 2005-04-25
• Target enrollment: 0
• Participant gender: All

Summary

A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.
• Treatments: Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Patients have type 2 diabetes mellitus

• On diet/exercise therapy

Exclusion Criteria:

• Patients have type 1 diabetes mellitus